CDOP regimen: Difference between revisions
Created page with "__NOTOC__ {{SI}} {{CMG}}; {{AE}} {{AV}} ==Overview== {{PAGENAME}} refers to an immunochemotherapy regimen consisting of Cyclophosphamide, Doxorubicin|Doxorubicin (Doxil..." |
No edit summary |
||
| Line 6: | Line 6: | ||
{{PAGENAME}} refers to an immunochemotherapy regimen consisting of [[Cyclophosphamide]], [[Doxorubicin|Doxorubicin (Doxil)]], [[Vincristine|Vincristine (Oncovin)]], [[Prednisone]] used to treat [[Diffuse large B-cell lymphoma]] | {{PAGENAME}} refers to an immunochemotherapy regimen consisting of [[Cyclophosphamide]], [[Doxorubicin|Doxorubicin (Doxil)]], [[Vincristine|Vincristine (Oncovin)]], [[Prednisone]] used to treat [[Diffuse large B-cell lymphoma]] | ||
==Regimen== | ==Regimen== | ||
{{chemo|C|Cyclophosphamide}} | |||
{{chemo|D|Doxorubicin Liposomal (Doxil)}} | |||
{{chemo|O|Vincristine (Oncovin)}} | |||
{{chemo|P|Prednisone}} | |||
==Indications== | ==Indications== | ||
*[[Diffuse large B-cell lymphoma]]<ref name="pmid12161358">{{cite journal| author=Martino R, Perea G, Caballero MD, Mateos MV, Ribera JM, de Oteyza JP et al.| title=Cyclophosphamide, pegylated liposomal doxorubicin (Caelyx), vincristine and prednisone (CCOP) in elderly patients with diffuse large B-cell lymphoma: results from a prospective phase II study. | journal=Haematologica | year= 2002 | volume= 87 | issue= 8 | pages= 822-7 | pmid=12161358 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12161358 }} </ref> | *[[Diffuse large B-cell lymphoma]]<ref name="pmid12161358">{{cite journal| author=Martino R, Perea G, Caballero MD, Mateos MV, Ribera JM, de Oteyza JP et al.| title=Cyclophosphamide, pegylated liposomal doxorubicin (Caelyx), vincristine and prednisone (CCOP) in elderly patients with diffuse large B-cell lymphoma: results from a prospective phase II study. | journal=Haematologica | year= 2002 | volume= 87 | issue= 8 | pages= 822-7 | pmid=12161358 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12161358 }} </ref> | ||
Latest revision as of 14:47, 11 March 2015
|
WikiDoc Resources for CDOP regimen |
|
Articles |
|---|
|
Most recent articles on CDOP regimen Most cited articles on CDOP regimen |
|
Media |
|
Powerpoint slides on CDOP regimen |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on CDOP regimen at Clinical Trials.gov Clinical Trials on CDOP regimen at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on CDOP regimen
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on CDOP regimen Discussion groups on CDOP regimen Patient Handouts on CDOP regimen Directions to Hospitals Treating CDOP regimen Risk calculators and risk factors for CDOP regimen
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for CDOP regimen |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Overview
CDOP regimen refers to an immunochemotherapy regimen consisting of Cyclophosphamide, Doxorubicin (Doxil), Vincristine (Oncovin), Prednisone used to treat Diffuse large B-cell lymphoma
Regimen
CCyclophosphamide
DDoxorubicin Liposomal (Doxil)
OVincristine (Oncovin)
PPrednisone
Indications
References
- ↑ Martino R, Perea G, Caballero MD, Mateos MV, Ribera JM, de Oteyza JP; et al. (2002). "Cyclophosphamide, pegylated liposomal doxorubicin (Caelyx), vincristine and prednisone (CCOP) in elderly patients with diffuse large B-cell lymphoma: results from a prospective phase II study". Haematologica. 87 (8): 822–7. PMID 12161358.